The average levels of IL-6 in the untreated NSCLC patients, COPD patients and controls were 33.4±7.7 pg/ml, 8.8±2.4 pg/ml and 7.2±2.4 pg/ml, respectively. Here, IL6 is linked to non-small cell lung carcinoma.